These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 3911152

  • 1. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M, Benevent D, Denis F.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
    Whitby M, Edwards R, Aston E, Finch RG.
    J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Harford AM, Sica DA, Tartaglione T, Polk RE, Dalton HP, Poynor W.
    Nephron; 1986 Mar; 43(3):217-22. PubMed ID: 3724930
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis.
    Tomino Y, Fukui M, Hamada C, Inoue S, Osada S.
    Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717
    [Abstract] [Full Text] [Related]

  • 5. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 2000 Aug; 16():280-4. PubMed ID: 11045311
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
    Vargemezis V, Pasadakis P, Thodis H, Coucudis P, Peihaberis P, Jafer H, Jara F, Kartali S.
    Adv Perit Dial; 1989 Aug; 5():128-9. PubMed ID: 2577394
    [Abstract] [Full Text] [Related]

  • 7. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis].
    Thomae U, Koblinger S.
    Med Klin (Munich); 1994 Sep 15; 89(9):464-8. PubMed ID: 7968880
    [Abstract] [Full Text] [Related]

  • 8. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis].
    Kostić S, Ljuvenović S, Velicković R, Stefanović V, Raicević R, Cukuranović R, Veljković S, Djordjević V, Malobabić Z.
    Srp Arh Celok Lek; 1996 Sep 15; 124 Suppl 1():149-51. PubMed ID: 9102884
    [Abstract] [Full Text] [Related]

  • 9. Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients.
    Were AJ, Marsden A, Tooth A, Ramsden R, Mistry CD, Gokal R.
    Clin Nephrol; 1992 Apr 15; 37(4):209-13. PubMed ID: 1582059
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics].
    Denis F, Mounier M, Lagarde C, Benevent D.
    Pathol Biol (Paris); 1987 May 15; 35(5):652-5. PubMed ID: 3302879
    [Abstract] [Full Text] [Related]

  • 11. Oral treatment of CAPD-peritonitis with ciprofloxacin.
    Boeschoten EW, Kuijper EJ, Speelman P, Struijk DG, Krediet RT, Arisz L.
    Adv Perit Dial; 1990 May 15; 6():126-9. PubMed ID: 1982789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K, Nakamoto H, Okada S, Hoshitani K, Uchida K, Arima H, Shoda J, Takane Y, Ikeda N, Sugahara S, Okada H, Suzuki H.
    Adv Perit Dial; 2006 May 15; 22():65-8. PubMed ID: 16983942
    [Abstract] [Full Text] [Related]

  • 14. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G, Schaefer F, Müller-Wiefel D, Mehls O.
    Adv Perit Dial; 1995 May 15; 11():296-301. PubMed ID: 8534728
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hearing thresholds in CAPD patients.
    Morton LP, Reynolds L, Zent R, Rayner BL.
    Adv Perit Dial; 1992 May 15; 8():150-2. PubMed ID: 1361774
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC, Jeong TK, Lee SC, Kim SW, Kim NH, Lee KY.
    Adv Perit Dial; 1998 May 15; 14():173-9. PubMed ID: 10649719
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical assessment of CAPD (continuous ambulatory peritoneal dialysis) for chronic end-stage renal failure].
    Ohira S, Abe K, Kon T.
    Hokkaido Igaku Zasshi; 1984 Jul 15; 59(4):478-87. PubMed ID: 6386640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.